Ebb D - Search Results

1

Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws.

Kaban LB, Troulis MJ, Ebb D, August M, Hornicek FJ, Dodson TB. Kaban LB, et al. Among authors: ebb d. J Oral Maxillofac Surg. 2002 Oct;60(10):1103-11; discussion 1111-3. doi: 10.1053/joms.2002.34975. J Oral Maxillofac Surg. 2002. PMID: 12378481

2

Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a.

Kaban LB, Mulliken JB, Ezekowitz RA, Ebb D, Smith PS, Folkman J. Kaban LB, et al. Among authors: ebb d. Pediatrics. 1999 Jun;103(6 Pt 1):1145-9. doi: 10.1542/peds.103.6.1145. Pediatrics. 1999. PMID: 10353921

3

Adjuvant antiangiogenic therapy for giant cell tumors of the jaws.

Kaban LB, Troulis MJ, Wilkinson MS, Ebb D, Dodson TB. Kaban LB, et al. Among authors: ebb d. J Oral Maxillofac Surg. 2007 Oct;65(10):2018-24; discussion 2024. doi: 10.1016/j.joms.2007.03.030. J Oral Maxillofac Surg. 2007. PMID: 17884531 Clinical Trial.

4

Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma.

Ciernik IF, Niemierko A, Harmon DC, Kobayashi W, Chen YL, Yock TI, Ebb DH, Choy E, Raskin KA, Liebsch N, Hornicek FJ, Delaney TF. Ciernik IF, et al. Cancer. 2011 Oct 1;117(19):4522-30. doi: 10.1002/cncr.26037. Epub 2011 Mar 29. Cancer. 2011. PMID: 21448934 Free PMC article.

5

Do histologic criteria predict biologic behavior of giant cell lesions?

Peacock ZS, Resnick CM, Susarla SM, Faquin WC, Rosenberg AE, Nielsen GP, Schwab JH, Hornicek F, Ebb DH, Dodson TB, Kaban LB. Peacock ZS, et al. J Oral Maxillofac Surg. 2012 Nov;70(11):2573-80. doi: 10.1016/j.joms.2011.12.005. Epub 2012 Feb 25. J Oral Maxillofac Surg. 2012. PMID: 22365980

6

Adjuvant Antiangiogenic Treatment for Aggressive Giant Cell Lesions of the Jaw: A 20-Year Experience at Massachusetts General Hospital.

Schreuder WH, Peacock ZS, Ebb D, Chuang SK, Kaban LB. Schreuder WH, et al. Among authors: ebb d. J Oral Maxillofac Surg. 2017 Jan;75(1):105-118. doi: 10.1016/j.joms.2016.06.007. Epub 2016 Jun 14. J Oral Maxillofac Surg. 2017. PMID: 27393579

7

Genetic Analysis of Giant Cell Lesions of the Maxillofacial and Axial/Appendicular Skeletons.

Peacock ZS, Schwab JH, Faquin WC, Hornicek FJ, Benita Y, Ebb DH, Kaban LB. Peacock ZS, et al. J Oral Maxillofac Surg. 2017 Feb;75(2):298-308. doi: 10.1016/j.joms.2016.07.014. Epub 2016 Jul 26. J Oral Maxillofac Surg. 2017. PMID: 27546031

8

Characteristics and Predictors for Secondary Leukemia and Myelodysplastic Syndrome in Ewing and Osteosarcoma Survivors.

Sanford NN, Miao R, Wang H, Goldberg S, Jacobson A, Brunner AM, Cote GM, Yock TI, Ebb DH, Chen YB, Jee KW, Hornicek F, DeLaney TF, Choy E, Chen YL. Sanford NN, et al. Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):52-61. doi: 10.1016/j.ijrobp.2018.08.037. Epub 2018 Aug 28. Int J Radiat Oncol Biol Phys. 2019. PMID: 30165126

9

Giant Cell Lesions of the Maxillofacial Skeleton Express RANKL by RNA In Situ Hybridization Regardless of Histologic Pattern.

Stagner AM, Sajed DP, Nielsen GP, Ebb DH, Faquin WC, Chebib I, Rivera MN, Ting DT, Resnick CM, Peacock ZS, Kaban LB, Deshpande V. Stagner AM, et al. Am J Surg Pathol. 2019 Jun;43(6):819-826. doi: 10.1097/PAS.0000000000001257. Am J Surg Pathol. 2019. PMID: 30998511

10

MicroRNA-mRNA networks define translatable molecular outcome phenotypes in osteosarcoma.

Lietz CE, Garbutt C, Barry WT, Deshpande V, Chen YL, Lozano-Calderon SA, Wang Y, Lawney B, Ebb D, Cote GM, Duan Z, Hornicek FJ, Choy E, Petur Nielsen G, Haibe-Kains B, Quackenbush J, Spentzos D. Lietz CE, et al. Among authors: ebb d. Sci Rep. 2020 Mar 10;10(1):4409. doi: 10.1038/s41598-020-61236-3. Sci Rep. 2020. PMID: 32157112 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters